Federal Circuit Affirms Invalidity of UV Sterilization Patent in Neister v. Eden Park
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Neister v. Eden Park Illumination |
| Case Number | 24-1374 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District of Columbia |
| Duration | Jan 2024 – Jan 2026 2 years |
| Outcome | Defendant Win — Invalidity Affirmed |
| Patent at Issue | |
| Technology at Issue | UV Sterilization Apparatus & Method |
Case Overview
The Parties
⚖️ Plaintiff
Individual inventor-patentee asserting rights in UV sterilization technology, a sector that experienced significant commercial expansion.
🛡️ Defendant
Company operating in the photonics and UV lighting space, with product lines relevant to disinfection markets.
Patent at Issue
This landmark case involved the validity of a key utility patent covering UV-based air and surface sterilization technology. Utility patents are registered with the U.S. Patent and Trademark Office (USPTO) and protect functional inventions rather than ornamental appearance.
- • US 9,700,642 B2 — Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination
Developing UV sterilization technology?
Check if your UV sterilization product might face invalidity challenges from prior art before launch.
The Verdict & Legal Analysis
Outcome
The Federal Circuit issued a clean affirmance in Case No. 24-1374, upholding the prior tribunal’s ruling on patentability grounds. This outcome means US9700642B2 was found invalid, with no damages or injunctive relief awarded.
Key Legal Issues
The Federal Circuit’s analysis centered on the patentability of US9700642B2, specifically addressing invalidity challenges under statutory grounds such as 35 U.S.C. §§ 102 and 103 (anticipation and obviousness) or 35 U.S.C. § 112 (written description, enablement, and definiteness). The affirmance indicates that the invalidity case, likely built on extensive prior art in UV-C disinfection systems, was well-supported and no reversible error was found in the lower court’s determination.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in UV sterilization technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific invalidity risks and implications from this litigation.
- View all related prior art in the UV sterilization space
- See which companies are most active in UV patents
- Understand claim construction patterns for similar technologies
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own UV sterilization technology or product.
- Input your product description or technical features
- AI identifies potentially blocking or vulnerable patents
- Get actionable risk assessment report
High Invalidity Risk
For overly broad UV sterilization claims
Extensive Prior Art
In UV-C disinfection systems
Design Freedom for Some
Previously constrained technology areas
✅ Key Takeaways
Federal Circuit affirmed invalidity of UV sterilization patent US9700642B2 in Case No. 24-1374.
Search related case law →Invalidity/Cancellation Actions remain a highly effective defense strategy in antimicrobial technology patent disputes.
Explore precedents →UV sterilization patent portfolios warrant proactive validity audits before enforcement.
Start a portfolio audit →FTO analyses in UV-C and antimicrobial technology should evaluate both patent existence and realistic validity risk.
Start FTO analysis for my product →Invalidated patents in this space may open design freedom previously perceived as constrained.
Explore the UV patent landscape →Frequently Asked Questions
The case concerned US Patent No. 9,700,642 B2 (Application No. US14/254957), covering a method and apparatus for sterilizing and disinfecting air and surfaces and protecting zones from microbial contamination.
The court affirmed on patentability grounds, upholding an invalidity/cancellation determination against the patent claims. Specific legal reasoning from the opinion was not available in the case data reviewed.
The affirmance reinforces that broad antimicrobial apparatus claims face significant invalidity risk, encouraging defendants to pursue patentability challenges early and patent holders to strengthen prosecution records.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- United States Court of Appeals for the Federal Circuit — Case 24-1374
- U.S. Patent No. 9,700,642 B2 (Google Patents)
- U.S. Patent and Trademark Office — Patent Resources
- PACER Federal Court Records
- Cornell Legal Information Institute — 35 U.S.C. § 102
- Cornell Legal Information Institute — 35 U.S.C. § 103
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Product?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis.
Run FTO for My Product